Gildan Rises After Strong Q2, Updated 2026 Outlook, and Australia Divestiture Plan

Gildan Activewear (GIL) is up 5.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a strong second-quarter report released on July 30, 2026, which showed solid profitability, ongoing HanesBrands integration progress, and an updated full-year outlook. Investors also likely responded well to plans to sell the HanesBrands Australia business, a step that would bring in cash and help reduce debt.

Details:

Second-quarter net sales from continuing operations reached $1.58 billion, while adjusted diluted earnings per share from continuing operations rose to $1.28, up 32% from the prior year.

Adjusted operating margin came in at 22.3%, well above the company’s prior guidance of around 19.7%, helped by lower raw material costs, pricing actions, and integration-related benefits.

Gildan said it remains on pace to capture about $100 million of synergies in 2026 from the HanesBrands integration and still expects about $250 million of annual run-rate cost synergies over three years.

The company also announced an agreement to sell HanesBrands Australia for an enterprise valuation of about 700 million Australian dollars, with proceeds intended to pay down debt and speed its return toward target leverage levels.

Sources:

Gildan, SEC

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$GIL Hedge Fund Activity

We have seen 162 institutional investors add shares of $GIL stock to their portfolio, and 241 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAISSE DE DEPOT ET PLACEMENT DU QUEBEC added 4,201,280 shares (+67.3%) to their portfolio in Q1 2026, for an estimated $233,801,232
SACHEM HEAD CAPITAL MANAGEMENT LP added 4,140,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $230,391,000
BEUTEL, GOODMAN & CO LTD. added 3,418,154 shares (+inf%) to their portfolio in Q1 2026, for an estimated $190,220,270
BRANDES INVESTMENT PARTNERS, LP removed 1,598,946 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $88,981,344
FIL LTD removed 1,482,106 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $82,479,198
ROYAL BANK OF CANADA added 1,193,718 shares (+20.9%) to their portfolio in Q1 2026, for an estimated $66,430,406
RUBRIC CAPITAL MANAGEMENT LP added 1,139,392 shares (+444.4%) to their portfolio in Q1 2026, for an estimated $63,407,164

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$GIL Congressional Stock Trading

Members of Congress have traded $GIL stock 7 times in the past 6 months. Of those trades, 6 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $GIL stock by members of Congress over the last 6 months:

REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/02 and 1 sale worth up to $15,000 on 06/17.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 5 purchases worth up to $75,000 on 05/11, 04/29, 04/27, 04/24, 04/22 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$GIL Price Targets

Multiple analysts have issued price targets for $GIL recently. We have seen 2 analysts offer price targets for $GIL in the last 6 months, with a median target of $71.5.

Here are some recent targets:

John Zamparo from Scotiabank set a target price of $65.0 on 06/17/2026
Ryland Conrad from RBC Capital set a target price of $78.0 on 03/02/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.